Dr. Manojkumar Bupathi

Dr. Manojkumar Bupathi, MD, MPH, is a well-regarded medical oncologist specializing in gastrointestinal cancers, sarcomas, and immunotherapy-based treatments. He serves as a medical oncologist at Rocky Mountain Cancer Centers, part of the US Oncology Network, where he is actively involved in both patient care and clinical research. Dr. Bupathi earned his medical degree from Texas A&M Health Science Center College of Medicine and completed his residency in internal medicine at the University of Colorado. He went on to pursue fellowship training in hematology and oncology at the University of Colorado Cancer Center, where he developed expertise in experimental therapeutics and translational oncology. He is board-certified in Internal Medicine, Hematology, and Medical Oncology.

Deeply engaged in clinical trial development, Dr. Bupathi has served as a principal investigator for numerous studies focused on targeted therapy and immunotherapy approaches for solid tumors. His research interests include novel drug development, biomarkers of response, and expanding treatment options for rare and aggressive cancers. He has authored peer-reviewed publications and presented his research at national oncology conferences, contributing to the advancement of precision medicine in community-based care.

Alongside his clinical and research activities, Dr. Bupathi is recognized for his patient-centered approach to oncology, emphasizing education, communication, and shared decision-making. He is also committed to mentoring early-career physicians and fostering collaboration between academic and community oncology practices. Through his dedication to advancing research and improving patient care, Dr. Manojkumar Bupathi continues to contribute meaningfully to the progress of gastrointestinal and sarcoma oncology.